These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1328376

  • 21. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T, Kanagawa R, Ishimura Y, Inada Y, Nishikawa K.
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [Abstract] [Full Text] [Related]

  • 22. Angiotensinogen dependency of blood pressure in two high-renin hypertensive rat models.
    Gahnem F, von Lutterotti N, Camargo MJ, Laragh JH, Sealey JE.
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):899-904. PubMed ID: 7826553
    [Abstract] [Full Text] [Related]

  • 23. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats.
    Soltis EE.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197
    [Abstract] [Full Text] [Related]

  • 24. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M, Suzuki H, Naitoh M, Matsumoto A, Kageyama Y, Tsujimoto G, Saruta T.
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [Abstract] [Full Text] [Related]

  • 25. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB, Black MJ, Bertram JF, Bobik A.
    J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
    [Abstract] [Full Text] [Related]

  • 26. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats.
    Hirawa N, Uehara Y, Kawabata Y, Ohshima N, Ono H, Nagata T, Gomi T, Ikeda T, Goto A, Yagi S.
    J Hypertens; 1994 Aug; 12(8):909-18. PubMed ID: 7814850
    [Abstract] [Full Text] [Related]

  • 27. Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan.
    Hajj-Ali AF, Wong PC.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1423-7. PubMed ID: 7903389
    [Abstract] [Full Text] [Related]

  • 28. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
    Garcia R, Bonhomme MC, Diebold S.
    J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin II receptor antagonist markedly reduces mortality in salt-loaded Dahl S rats.
    von Lutterotti N, Camargo MJ, Mueller FB, Timmermans PB, Laragh JH.
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):346S-349S. PubMed ID: 1854463
    [Abstract] [Full Text] [Related]

  • 30. Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats.
    Wong PC, Christ DD, Timmermans PB.
    Eur J Pharmacol; 1992 Sep 22; 220(2-3):267-70. PubMed ID: 1425998
    [Abstract] [Full Text] [Related]

  • 31. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
    MacFadyen RJ, Tree M, Lever AF, Reid JL.
    Clin Sci (Lond); 1992 Nov 22; 83(5):549-56. PubMed ID: 1335390
    [Abstract] [Full Text] [Related]

  • 32. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
    Goldberg MR, Bradstreet TE, McWilliams EJ, Tanaka WK, Lipert S, Bjornsson TD, Waldman SA, Osborne B, Pivadori L, Lewis G.
    Hypertension; 1995 Jan 22; 25(1):37-46. PubMed ID: 7843751
    [Abstract] [Full Text] [Related]

  • 33. Angiotensin blockade prevents salt-induced injury of the renal circulation in spontaneously hypertensive rats.
    Susic D, Zhou X, Frohlich ED.
    Am J Nephrol; 2009 Jan 22; 29(6):639-45. PubMed ID: 19155618
    [Abstract] [Full Text] [Related]

  • 34. Reduction of development of left ventricular hypertrophy in salt-loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition.
    de Simone G, Devereux RB, Camargo MJ, Wallerson DC, Sealey JE, Laragh JH.
    Am J Hypertens; 1996 Mar 22; 9(3):216-22. PubMed ID: 8695019
    [Abstract] [Full Text] [Related]

  • 35. DuP 753 increases survival in spontaneously hypertensive stroke-prone rats fed a high sodium diet.
    Camargo MJ, von Lutterotti N, Pecker MS, James GD, Timmermans PB, Laragh JH.
    Am J Hypertens; 1991 Apr 22; 4(4 Pt 2):341S-345S. PubMed ID: 1854462
    [Abstract] [Full Text] [Related]

  • 36. Midwall left ventricular performance in salt-loaded Dahl rats: effect of AT1 angiotensin II inhibition.
    de Simone G, Devereux RB, Camargo MJ, Wallerson DC, Sealey JE, Laragh JH.
    J Hypertens; 1995 Dec 22; 13(12 Pt 2):1808-12. PubMed ID: 8903657
    [Abstract] [Full Text] [Related]

  • 37. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.
    Goldberg MR, Tanaka W, Barchowsky A, Bradstreet TE, McCrea J, Lo MW, McWilliams EJ, Bjornsson TD.
    Hypertension; 1993 May 22; 21(5):704-13. PubMed ID: 8491505
    [Abstract] [Full Text] [Related]

  • 38. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure.
    Morton JJ, Beattie EC, MacPherson F.
    J Vasc Res; 1992 May 22; 29(3):264-9. PubMed ID: 1387008
    [Abstract] [Full Text] [Related]

  • 39. The effects of angiotensin II receptor blockade with losartan on systemic blood pressure and renal and extrarenal prostaglandin synthesis in women with essential hypertension.
    Smith MC, Barrows S, Meibohm A, Shahinfar S, Simpson RL, Weigel K, Dunn MJ.
    Am J Hypertens; 1995 Dec 22; 8(12 Pt 1):1177-83. PubMed ID: 8998251
    [Abstract] [Full Text] [Related]

  • 40. Blood pressure, magnesium and other mineral balance in two rat models of salt-sensitive, induced hypertension: effects of a non-peptide angiotensin II receptor type 1 antagonist.
    Rondón LJ, Marcano E, Rodríguez F, del Castillo JR.
    Magnes Res; 2014 Dec 22; 27(3):113-30. PubMed ID: 25560239
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.